Results 161 to 170 of about 1,782,190 (315)

ZW4864‐mediated inhibition of the β‐catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer

Molecular Oncology, EarlyView.
BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi, Mandy Berndt‐Paetz, Eileen Lerner, Gregoire Najjar, Anca Azoitei, Krishna Pal Singh, Shailendra Kumar Gupta, Olaf Wolkenhauer, Cagatay Günes, Otmar Huber, Marc‐Oliver Grimm, Daniel Steinbach   +11 more
wiley   +1 more source

Targeted proteoform degradation for precision drug design, delivery, and therapy. [PDF]

Drug Deliv
Cui C, Zhang H, Wang X, Li N, Zhan X.
europepmc   +1 more source

Mycobacterial cell division arrest and smooth‐to‐rough envelope transition using CRISPRi‐mediated genetic repression systems

FEBS Open Bio, EarlyView.
CRISPRI‐mediated gene silencing and phenotypic exploration in nontuberculous mycobacteria. In this Research Protocol, we describe approaches to control, monitor, and quantitatively assess CRISPRI‐mediated gene silencing in M. smegmatis and M. abscessus model organisms.
Vanessa Point, Wafaa Achache, Janïs Laudouze, Eliana Sepulveda Ramos, Mickaël Maziero, Céline Crauste, Stéphane Canaan, Pierre Santucci   +7 more
wiley   +1 more source

In Silico Drug Design and Discovery: Big Data for Small Molecule Design-2nd Edition. [PDF]

Biomolecules
Cerchia C, Lavecchia A.
europepmc   +1 more source

PARP inhibitors induce a senescence phenotype in non‐small cell lung carcinoma cell lines

FEBS Open Bio, EarlyView.
Talazoparib is the most potent inducer of senescence among different PARP1 inhibitors in human NSCLC cells. In the absence of PARP, no senescence phenotype was observed, demonstrating that PARP1 is necessary for the induction of senescence by this inhibitor.
Camille Huart, Manon Van den Abbeel, Christoph Schifflers, Karim Bouhjar, Andrea Scarmelotto, Alexis Khelfi, Anne‐Catherine Wera, Carine Michiels   +7 more
wiley   +1 more source

Alterated expression of extra-cellular matrix proteins and integrin receptors in discoid lupus erythematosus

, 2004
GIANNELLI, Gianluigi, ANGELINI G, LETTERS IN DRUG DESIGN DISCOVERY, SGARRA C, BERGAMINI C, ANTONACI S., ., FOTI, Caterina, COVIELLO C   +8 more
core   +1 more source

The role of L-Arginine metabolism in the hallmarks of cancer as an emerging pathway to drug design. [PDF]

Front Pharmacol
Garcia-Valdez G, Vazquez-Galvan AE, Gonzalez-Llerena JL, Treviño-Almaguer D, Gallegos-Ibarra DL, Guajardo-Gonzalez D, Balderas-Renteria I, Camacho-Corona MDR, Espinosa-Rodriguez BA.   +8 more
europepmc   +1 more source

Structural and functional characterization of self-assembling amphiphilic oligopeptides

, 2009
The aim of this thesis was to design amphiphilic peptides that self-assemble into supramolecular structures, like nano-sized vesicles that can be of use for drug delivery purposes.
Dep Farmaceutische wetenschappen, van Hell, A.J., Advanced drug delivery systems/drug targeting   +2 more
core  

Identification of functional murine mitochondrial formyl peptides and their effects on myeloid‐derived suppressor cell generation

FEBS Open Bio, EarlyView.
We first identified functional murine mitochondrial N‐formyl peptides (MT‐FPs) and investigated their effects on the in vitro myeloid‐derived suppressor cell (MDSC) generation from bone marrow cells. We demonstrated that MT‐FPs acted directly on bone marrow cells to promote MDSC generation and modulated the polymorphonuclear (PMN)‐MDSC/monocyte (M ...
Miyako Ozawa, Saori Kagoshima, Akira Yamada   +2 more
wiley   +1 more source

The Multifaceted Legacy of Thalidomide: Chemistry and Biology Driving Modern Drug Design. [PDF]

ChemMedChem
Nikovia K, Kapsalis M, Georgoulakis M, Panousis A, Neochoritis CG.   +4 more
europepmc   +1 more source